Affymax Rises the Most Since 2006: San Francisco Mover

Affymax Inc. rose the most ever in New York trading, about 10 days after the drugmaker recalled its anemia treatment Omontys because of reports three people had fatal reactions to the medicine.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.